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Abstract Multi-criteria decision analysis (MCDA) is
increasingly used to support decisions in healthcare
involving multiple and conflicting criteria. Although
uncertainty is usually carefully addressed in health eco-
nomic evaluations, whether and how the different sources
of uncertainty are dealt with and with what methods in
MCDA is less known. The objective of this study is to
review how uncertainty can be explicitly taken into account
in MCDA and to discuss which approach may be appro-
priate for healthcare decision makers. A literature review
was conducted in the Scopus and PubMed databases. Two
reviewers independently categorized studies according to
research areas, the type of MCDA used, and the approach
used to quantify uncertainty. Selected full text articles were
read for methodological details. The search strategy iden-
tified 569 studies. The five approaches most identified were
fuzzy set theory (45 % of studies), probabilistic sensitivity
analysis (15 %), deterministic sensitivity analysis (31 %),
Bayesian framework (6 %), and grey theory (3 %). A large
number of papers considered the analytic hierarchy process
in combination with fuzzy set theory (31 %). Only 3 % of
studies were published in healthcare-related journals. In
conclusion, our review identified five different approaches
to take uncertainty into account in MCDA. The determin-
istic approach is most likely sufficient for most healthcare
policy decisions because of its low complexity and
straightforward implementation. However, more complex
approaches may be needed when multiple sources of
uncertainty must be considered simultaneously.
Key Points for Decision Makers
Multi-criteria decision analysis is increasingly used
in healthcare, but guidance is lacking on how to
quantify and incorporate uncertainty.
This review identified five commonly used
approaches to quantify and incorporate uncertainty:
deterministic sensitivity analyses, probabilistic
sensitivity analyses, Bayesian frameworks, fuzzy set
theory, and grey theory.
A simple approach that will most likely be sufficient
for most decisions is deterministic sensitivity
analysis, although more complex approaches may be
needed when multiple sources of uncertainty must be
considered simultaneously.
1 Introduction
Over the last decade, researchers in outcomes research
have increasingly suggested multi-criteria decision analysis
(MCDA) as an approach to support healthcare decisions
[1]. MCDA is an extension of decision theory that supports
decision makers (policy makers, regulators, managers) who
have multiple (possibly conflicting) objectives by
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decomposing the decision objectives into criteria [2]. These
criteria are given a numeric importance weight and deci-
sion alternatives such as drugs or treatments are scored on
each of the criteria. The criteria weights and performances
scores are then aggregated into an overall score, which is
used to rank the alternative treatments. For a more detailed
overview of the subsequent steps in MCDA, the reader is
referred to Belton and Steward [2] and Hummel et al. [3].
MCDA is considered to be a transparent and flexible
approach [4–7]. It has been used to support a wide range of
decisions, such as in portfolio optimization, benefit-risk
assessment, health technology assessment, and shared
decision making [8–13]. Although the objectives differ,
these decisions share three characteristics. First, they are
characterized by possibly conflicting decision criteria
where trade-offs between criteria influence the decision.
Second, the criteria to operationalize can be qualitative,
quantitative, or a combination of both. Finally, these
decisions and underlying criteria weights and performance
scores are characterized by uncertainty.
In principle, several sources of uncertainty can be dis-
tinguished and have been clearly described by different
authors [14, 15]. In their comprehensive taskforce report,
Briggs et al. [15] define four types of uncertainty: sto-
chastic uncertainty, parameter uncertainty, heterogeneity,
and structural uncertainty. Although their report discusses
uncertainty in decision analytic models in general, this
classification is almost identical for MCDA. However, in
MCDA, the four types of uncertainty are relevant to con-
sider for both the weighting of criteria and the scoring of
alternatives. Criteria weights are always elicited from
decision makers, and stochastic uncertainty in weighting is
therefore random variability in weights as assigned by
otherwise identical persons. Parameter uncertainty refers to
the estimation error of an estimated quantity, for example,
the mean weight given by a group of decision makers to a
criterion. Heterogeneity is explainable variation in weights,
for example owing to a person’s background characteris-
tics. Finally, structural uncertainty occurs when decision
makers are unsure if all relevant decision criteria are
included and how these criteria are structured [14].
Like criteria weights, the performance scores of alter-
natives can be obtained through elicitation. Alternatively,
performance scores can be obtained from other data sour-
ces such as registries or clinical trials. If performance
scores are elicited from decision makers, generally the
same sources of uncertainty apply as in the weighting step.
If data are obtained from other data sources (such as an
odds ratio comparing two drugs derived from a clinical
trial), stochastic uncertainty, parameter uncertainty, and
heterogeneity stems from variation or uncertainty in the
source data. Structural uncertainty, however, is relevant to
consider in these instances as it refers to how the outcomes
are measured and how the data are transformed to a per-
formance score in the MCDA. Often, performance scores
are assigned based on a structured appraisal of available
evidence. In that case, both elicitation- and data-specific
uncertainties are relevant, of which the mix depends on the
amount of available evidence. An overview of the types of
uncertainty and their source in MCDA is presented in
Table 1.
A recent systematic review by Marsh et al. identified 41
applications of MCDA in healthcare and found that deci-
sion makers are positive about the possibilities of MCDA
but that guidance on its application is lacking [16].
Twenty-two studies considered uncertainty, predominantly
with deterministic sensitivity analysis. Previous studies
outside the area of healthcare reviewed approaches to take
into account uncertainty in MCDA-supported decisions.
Durbach and Stewart [17] reviewed different approaches to
take into account uncertainty in the scoring of alternatives.
They identified: probability-based approaches, fuzzy
Table 1 Overview of types and sources of uncertainty in the context
of MCDA-supported decision making. On the left are the types of
uncertainty, as introduced by Briggs et al. [15]. In MCDA,
uncertainty is related to both the determination of criteria weights
and performance scores. Criteria weights are always elicited from
stakeholders or decision makers while performance scores can either
be elicited from stakeholders or derived from other data sources such
as registries and clinical trials
Definition of Briggs et al. [15] MCDA-specific definition
Type of uncertainty
Stochastic
uncertainty
Random variability in outcomes between identical
patients
Random variability in criteria weights or performance scores as assigned
by identical persons
Parameter
uncertainty
The uncertainty in estimation of the parameter of
interest
The uncertainty in estimation of the parameter (criterion weight or
performance score) of interest
Heterogeneity The variability between patients that can be
attributed to characteristics of those patients
Variability in criteria weights or performance scores that can be
attributed to a person’s characteristics
Structural
uncertainty
The assumptions inherent in the decision model Uncertainty about if all relevant criteria are included, if they are
properly structured and which transformations are used
MCDA multi-criteria decision analysis
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numbers, risk-based approaches, and scenario analysis.
Finally, a review by Kangas and Kangas [18] in the field of
forestry identified the frequentist, Bayesian, evidential
reasoning, fuzzy sets, probabilistic, and possibility theory
approaches.
Although the use of MCDA is emerging and uncertainty
clearly is a relevant issue in MCDA models, there currently
is no guidance on how uncertainty should be taken into
account. To account for uncertainty in MCDA, three sep-
arate steps are proposed: (1) first, the sources of uncertainty
need to be identified, followed by (2) an assessment of the
magnitude of the uncertainty, and finally (3) by an evalu-
ation whether the uncertainty would eventually lead to a
different decision.
The objective of the present study is threefold. First, the
study aims to identify common approaches to account for
uncertainty. The second objective is to classify the identi-
fied approaches according to their mathematical approach
and according to how the estimates for uncertainty are
derived. Finally, the approaches will be compared, and
their applicability for healthcare decisions will be dis-
cussed. In this discussion, the focus will be on approaches
that deal with elicitation-related uncertainty.
2 Methods
2.1 Identification of Studies
A literature search in the SCOPUS and PubMed databases
was performed for the period between 1960 and 2013 using
the following search terms: (MCDA OR multi criteria
decision analysis) AND (methodological OR parameter OR
structural OR stochastic OR subjective OR *) uncertainty,
multi criteria decision analysis AND (sensitivity OR
robustness OR scenario) analysis, uncertainty AND X, and
sensitivity analysis AND X. In these strings, an asterisk
represents a wildcard that can be matched by any word, and
X was replaced with each of the individual MCDA method
names, written both in full as well as in an abbreviated
form (see also Table 3). In addition to the database search,
reference lists were also searched. Non-English studies,
studies that did not apply or discuss MCDA, and studies
with an application of MCDA where uncertainty was not
taken into account were excluded.
2.2 Classification
Following the identification, all included studies were
classified by research area. This was done by coding the
publications (journals and conference proceedings) in
which the studies were published with their top-level All
Science Journal Classification (ASJC). If publications were
associated with multiple classifications, all were used for
the coding. To examine applications in healthcare, sub-
level ASJC codes related to healthcare were used (available
from authors on request).
Second, the studies were classified by the MCDA
method used. Only MCDA methods that were identified
twice or more were put in separate categories, all methods
that were used only once were put in the ‘‘other’’ category.
MCDA methods were separated into: value-based, out-
ranking, reference-based, or other/hybrid methods. Value-
based methods construct a single overall value for each
decision alternative. Low scores on one criterion can be
compensated by higher scores on another criterion. In
outranking methods, low scores on one criterion may not
be compensated by higher scores on another criterion.
Furthermore, incomparability between the performance
scores of alternatives is allowed. Reference-based methods
calculate the similarity of alternatives to an ideal and anti-
ideal alternative. The categorization was performed inde-
pendently by three reviewers (HB, CG, MH) and dis-
agreements were resolved through discussion. Full-text
articles were accessed when the used MCDA method could
not be identified from the abstract alone or in case of
continued disagreement between reviewers.
Third, two reviewers (HB, CG) independently classified
the studies by their approach to take into account uncertainty.
An initial list of approaches was defined based on the
authors’ past experiences. On this initial list were the
deterministic, probabilistic, Bayesian, and fuzzy set
approaches. Newly identified approaches were added to the
list. For every unique combination of an MCDAmethod and
an uncertainty approach, the most recent full-text article was
read. If needed, references of these articles were also read to
find methodological details or to identify textbooks.
3 Results from the Literature Review
3.1 Identification and Classification of Studies
A total of 569 studies were identified that were published
between 1986 and 2013. The number of published studies
increases sharply after the year 2000 (Fig. 1). Top-level
ASJC research areas that accounted for more than 10 % of
the included studies are engineering (21 %), computer sci-
ence (17 %), and environmental science (12 %), as pre-
sented in Table 2. Only 3 % of the included studies are
published in a publication with an ASJC related to health-
care. Most studies (88 %) use one MCDA method while
11 % use two and 1 % uses three. As seen in Table 3, the
analytic hierarchy process (AHP) was used most often
(52 %), followed by the technique for order of preferences
by similarity to ideal solution (TOPSIS) (9 %) and the
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preference ranking organization method for enrichment
evaluation (PROMETHEE) (7 %). For 15 % of studies, the
MCDAmethod used could not be identified from the abstract
alone and therefore required full-text reading.
3.2 Description of Identified Approaches
for Uncertainty Analysis
Following the identification of studies, five distinctly dif-
ferent approaches were identified: deterministic sensitivity
analysis, probabilistic sensitivity analysis, Bayesian
frameworks, fuzzy set theory, and grey theory. Fuzzy set
theory was most commonly identified (45 % of studies).
The frequency with which the identified approaches were
used in various research and application fields is presented
in Table 2, and Table 3 presents how often the uncertainty
approaches were combined with various MCDA methods.
For a comprehensive demonstration of the different
approaches, please refer to the Excel file in the electronic
supplementary material.
Table 2 Research areas of publications in which identified studies were published, as coded with the All Science Journal Classification (ASJC),
and the division of identified approaches over the research areas. Note that a publication can be associated with more than one ASJC
ASJC research area Bayesian
framework
Deterministic sensitivity
analysis
Fuzzy set
theory
Grey
theory
Probabilistic sensitivity
analysis
n (%)
Agricultural and biological
sciences
– 8 4 – 5 17 (2 %)
Business, management, and
accounting
4 27 31 3 15 80 (8 %)
Chemical engineering – 4 3 – 3 10 (1 %)
Chemistry – 1 4 – 4 9 (1 %)
Computer science 11 35 103 4 12 165 (17 %)
Decision sciences 8 33 30 2 27 100 (10 %)
Earth and planetary sciences 3 3 5 – 2 13 (1 %)
Economics, econometrics,
and finance
– 8 11 1 1 21 (2 %)
Energy – 20 5 1 4 30 (3 %)
Engineering 9 56 121 8 17 211 (21 %)
Environmental science 3 43 42 1 26 115 (12 %)
Materials science – 9 10 – 1 20 (2 %)
Mathematics 8 26 43 2 22 101 (10 %)
Medicine 1 10 8 – 4 23 (2 %)
Physics and astronomy – 1 3 1 2 7 (1 %)
Social sciences 3 13 19 – 9 44 (4 %)
Other – 6 7 1 3 17 (2 %)
Fig. 1 Distribution of identified
studies by their year of
publication and divided into the
approach in which they were
categorized
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3.2.1 Deterministic Sensitivity Analysis
Three types of deterministic sensitivity analyses were
identified: simple sensitivity analysis, threshold analysis,
and analysis of extremes [19]. In simple sensitivity ana-
lysis, one model parameter (a criteria weight or a perfor-
mance score) is varied at a time, and the impact of variation
on the rank order of alternatives is observed. If the induced
variation does not change the rank order of alternatives (i.e.
the preference of one alternative over the other), the
decision is considered robust [20, 21]. Both threshold
analysis and analysis of extremes are aimed at determining
how much model parameters need to change before a dif-
ferent rank order of alternatives is obtained [22].
3.2.2 Probabilistic Sensitivity Analysis
Probabilistic sensitivity analysis requires decision makers
to define probability distributions for model parameters.
For assigning probability distributions for performance
scores, decision makers can refer to descriptive statistics or
patient-level data from patient registries or clinical trials
[23, 24]. Methods to formally elicit probability distribu-
tions from (clinical) experts are also available [25]. For
model parameters for which there is little or no evidence,
non-informative distributions such as a uniform distribu-
tion can be used [26]. After propagating the uncertainty
through the MCDA model with Monte Carlo simulations,
probability distributions are obtained for each alternative’s
Table 3 Identified uncertainty approaches combined with existing
MCDA methods, the total number of abstracts per approach, and the
total number of abstracts per MCDA method. A single reference to a
relevant textbook is added next to each one of the MCDA method
names (if available, or a paper is cited). Some studies applied more
than one MCDA method and were counted for each method. aThe
name of this MCDA method was used in the search strategy. The
(English) meanings of the MCDA method abbreviations are as
follows. DRSA dominance-based rough set approach, ELECTRE
elimination and choice translating reality method, PROMETHEE
preference ranking organization method for enrichment evaluation,
AHP analytic hierarchy process, ANP analytic network process,
MACBETH measuring attractiveness by a categorical-based evalua-
tion technique, MCDA multi-criteria decision analysis, MAUT multi-
attribute utility theory, MAVT multi-attribute value theory, OWA
ordered weighted average, SAW simple additive weighting, SMAA
stochastic multi-criteria acceptability analysis, SMART simple multi-
attribute rating technique, WSM weighted sum method, ER evidential
reasoning, TOPSIS technique for order preference by similarity to an
ideal solution, VIKOR multicriteria optimization and compromise
solution, DMCE deliberative multi-criteria evaluation, TODIM inter-
active and multicriteria decision making
MCDA method Bayesian
framework
Deterministic sensitivity
analysis
Fuzzy set
theory
Grey
theory
Probabilistic sensitivity
analysis
n (%)
Outranking
DRSAa [77] – – – – 2 2 (0 %)
ELECTREa [72] 1 10 9 – 3 23 (3 %)
PROMETHEEa
[72]
1 17 14 1 17 50 (7 %)
Value based
AHPa [72] 18 116 174 6 34 348 (52 %)
ANP [72] – 7 10 – – 17 (3 %)
MACBETHa [72] 1 1 – – 1 3 (0 %)
MAUTa [72] 1 8 – – 5 14 (2 %)
MAVTa [2] – 6 – – 5 11 (2 %)
OWA [78] 3 1 12 – 2 18 (3 %)
SAW [78] – 4 2 1 2 9 (1 %)
SMAA [66] – – – – 10 10 (1 %)
SMARTa [79] – 2 – – 1 3 (0 %)
WSM [78] – 4 – – 3 7 (1 %)
Reference based
ER [77] 7 4 17 5 6 39 (6 %)
TOPSIS [72] – 6 45 2 4 57 (9 %)
VIKOR [80] – 2 5 – – 7 (1 %)
Other/hybrid
DMCE [81] – 2 1 – – 3 (0 %)
TODIM [82] – 1 1 – – 2 (0 %)
Other 5 9 16 8 8 46 (7 %)
n (%) 37 (6 %) 200 (30 %) 306 (46 %) 23 (3 %) 103 (15 %) 669 (100 %)
Uncertainty in MCDA 449
overall score, and probabilistic statements such as the
probability of a particular rank order of alternatives can be
made [26–28].
3.2.3 Bayesian Framework: Bayesian Networks
and Dempster–Shafer Theory
Both Bayesian networks and Dempster–Shafer theory use
the Bayesian framework to estimate the impact of
uncertainty on the outcome of an MCDA-supported
decision. Bayesian networks allow decision makers to
explicitly model the interdependency of decision-related
elements (for example, patient characteristics that may
impact treatment performance) as a directed acyclic
graph. Associated with each node in the graph are edges
(arrows between nodes) that show the conditional rela-
tionships between the node and its parents. If there is no
information about the conditional probabilities, prior dis-
tributions can be assumed. With more evidence, these
prior probabilities can be updated using Bayes’ theorem
[29, 30].
Dempster–Shafer theory is an evidential reasoning-
based method, which is an extension of the Bayesian
framework [31–33]. The five basic elements of Dempster–
Shafer theory are: the frame of discernment, probability
mass assignments, belief functions, plausibility functions,
and Dempster’s rule of combination. The frame of dis-
cernment is a set of hypotheses from which one hypothesis
with the most evidential support has to be chosen. In the
context of MCDA, choice alternatives can be considered as
the hypotheses; and the aim becomes to select the choice
alternative for which the most evidential support for being
the best choice (either for the whole decision or for a
specific criterion) exists [34]. The first step in such an
elicitation process consists of decision makers assigning a
probability mass to (sets of) hypotheses in the frame of
discernment, for example by indicating that there is evi-
dential support for treatment A and B being the best per-
forming treatments on a particular criterion. Then, lower
and upper bounds of evidential support (termed belief and
plausibility) are calculated per hypothesis, for example ‘the
evidential support for this hypothesis is between 50 and
80 %’. Finally, probability mass assignments from differ-
ent evidence sources (for example, different decision
makers) can be combined with Dempster’s rule of combi-
nation. An agreement metric between decision makers can
also be calculated.
3.2.4 Fuzzy Set Theory
In fuzzy set theory, elements have a degree of membership
to a set [35, 36]. The degree of an element’s membership to
a fuzzy set is expressed as a number between zero (not a
member of the fuzzy set) and one (completely a member of
the fuzzy set). Degrees of memberships between zero and
one indicate ambiguous set membership. Consider as
examples of fuzzy sets the sets of ‘‘very important criteria’’
or of ‘‘low criteria weights’’. If all memberships are equal
to either zero or one, fuzzy set theory reduces to conven-
tional set theory. When applying fuzzy set theory for
MCDA, decision makers first have to identify ambiguous
elements (such as particular criteria weights) in their
decision problem. They then have to define fuzzy sets and
the membership functions to capture the identified ambi-
guity. For example, the pairwise comparisons to establish
criteria weights in the AHP are conventionally numbers
between 1 (‘‘equivalence’’) and 9 (‘‘extreme preference’’)
[37]. When decision makers use AHP in combination with
fuzzy sets, statements such as ‘‘extreme preference’’ can be
ambiguous. The ambiguity in such statements can be rep-
resented with fuzzy sets [38, 39].
3.2.5 Grey theory
In grey theory, uncertainty can be represented with ran-
ges termed black, white, or gray numbers [40]. The
‘shade’ of a number indicates the magnitude of uncer-
tainty. Black numbers represent a complete lack of
knowledge (range is from minus infinity to plus infinity),
whereas white numbers represent complete knowledge
(range is a single number). Gray numbers are between
these extremes, for example a gray number with a lower
bound of 1 and an upper bound of 5. Like fuzzy sets,
gray numbers can be described by verbal statements: for
example, a performance score between 0 and 0.3 on a
particular criterion may be defined as ‘‘low’’ [41]. In an
MCDA context, grey theory requires decision makers to
provide lower and upper bounds for criteria weights or
performance scores. These yield bounds on the overall
treatment scores.
3.3 Applications in Healthcare
Nineteen applications of the approaches in healthcare-
related publications were identified. Of these, seven are
related to healthcare policy decisions. Nine studies in
healthcare used the deterministic approach [5, 42–49]. Of
these, four studies were in the context of (research) port-
folio optimization [42, 46, 47, 49], early health technology
assessment [46], and benefit-risk assessment [5]. The other
studies applying the deterministic approach were in emer-
gency management [43] and drinking water systems [44,
45]. Four studies in healthcare were categorized as prob-
abilistic [9, 23, 50, 51], of which two focus on benefit-risk
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assessments [9, 51], one on infectious diseases [23], and
one on water transport (safety) [50]. Four fuzzy set theory
studies considered environmental health issues [52–55],
while one considered diagnostics [56]. Finally, one study
applied a Bayesian framework for diagnostics [57].
4 Discussion
4.1 Comparison of Approaches
The present review was performed to identify and classify
the different approaches to quantify uncertainty in MCDA.
Five distinct approaches were identified: deterministic sen-
sitivity analysis, probabilistic sensitivity analysis, Bayesian
frameworks, fuzzy set theory, and grey theory. To guide our
discussion on the advantages and disadvantages of these
approaches for healthcare applications, we will discuss them
with respect to six criteria that are derived from earlier
studies that assessed the applicability of uncertainty
approaches for: operations research [58], forestry [18],
engineering [59], and health economic models [60]. Criteria
relating to what extent approaches can represent uncertainty
are inputs and outputs (how can decision makers assign
uncertainty to model parameters and what additional infor-
mation does the approach then yield) and the number of
uncertainty sources that can be taken into account. More
practical considerations are the versatility of the approaches
with regard to combining them with MCDA methods, time
considerations, and prerequisite knowledge.
Deterministic sensitivity analysis implies that weights
are varied as a single value and is therefore easy applicable
to both uncertainty in performance scores [20] and uncer-
tainty in criteria weights [61, 62]. If there is heterogeneity
in criteria performance scores and/or criteria weights,
scenario analysis can be used to compare the outcomes for
relevant subgroups [46, 63]. Drawbacks of deterministic
sensitivity analysis are that the range over which weights or
performance scores are varied is usually arbitrarily chosen
and that it is assumed that all parameter values in the range
are equally probable. These drawbacks may lead to a
biased view of the impact of uncertainty on the decision.
Probabilistic sensitivity analysis can address these partic-
ular drawbacks by allowing decision makers to assign
probability distributions estimating both stochastic and
parameter uncertainty.
Bayesian networks are especially relevant when there
are conditional relations in the evidence sources, which
obviously is present if confounded clinical endpoints
obtained from clinical studies are transformed to a per-
formance score. Bayesian networks seem therefore mostly
useful as a method to investigate the evidence before the
scoring step of alternatives in an MCDA. Dempster–Shafer
theory is most useful when little or no evidence is available
and an elicitation method is used to gather expert opinion
on the performance scores of treatments. Because human
judgment is often characterized by ambiguity [35, 64],
decision makers may accept fuzzy set theory more readily
than approaches that denote variation in criteria weights as
uncertain using terms like ‘deviation’ and ‘error’ [35]. In
grey theory, ranges can be defined for both criteria weights
and performance scores easily. However, this gives infor-
mation only about the bounds of model parameters such as
overall treatment scores and does not give insight into the
likelihood of values in between the bounds.
4.2 Widening the Application of Uncertainty Analysis
in MCDA for Healthcare
In an attempt to develop guidance for practitioners of
MCDA, the five approaches can be compared in terms of
how the required input is elicited and what additional
information the approaches yield about the magnitude and
impact of uncertainty. Three input modes are defined:
changing values, specifying ranges, and specifying distri-
butions. In ‘‘changing values’’, decision makers simply
take other values for the criteria weights and performance
scores. Although theoretically this can be done with any
approach, it is what deterministic sensitivity analysis was
designed specifically for. The output of such an analysis
can give decision makers more insight in the impact of the
induced variation on the overall treatment scores and on the
rank order of treatments. In ‘‘specifying ranges’’, decision
makers have to specify lower and upper bounds of model
parameters. This can be done with the probabilistic, gray,
and fuzzy set approaches. Grey theory was specifically
designed for this input mode. In probabilistic sensitivity
analysis, a uniform distribution between the lower and
upper bounds can be assigned. In fuzzy set theory, uniform
fuzzy sets can be defined between the lower and upper
bounds. The outputs yielded by the approaches differ when
using the ‘‘specifying ranges’’ input mode. The grey theory
approach will only provide insight into bounds for treat-
ment overall scores while the probabilistic and fuzzy
approaches also yield the distribution of overall treatment
scores between the bounds. Finally, by ‘‘specifying distri-
butions’’, decision makers state how values are distributed
over a range. Distributions can be specified in probabilistic
sensitivity analysis, Bayesian networks and fuzzy set the-
ory. As output the decision makers will gain insight into
the distribution of overall treatment scores. The overlap
between the distributions of overall treatment scores can be
used to assess the impact of uncertainty on the rank order
of treatments. In the probabilistic and Bayesian approa-
ches, this is operationalized as the probability of particular
rankings occurring.
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Deterministic sensitivity analysis is the only approach
that cannot take into account a larger number of uncertain
model parameters simultaneously and thus does not con-
sider the cumulative impact of uncertainty in multiple
model parameters. The probabilistic and Bayesian network
approaches can simultaneously take into account uncer-
tainty from multiple sources of uncertainty with Monte
Carlo simulations. In Dempster–Shafer theory, Dempster’s
rule of combination is used to combine the probability
mass assessments of multiple decision makers. Fuzzy sets
and gray numbers can be combined using the known
mathematical operations on sets and ranges [35, 65].
In this review, approaches to take into account uncer-
tainty are identified and classified according to their ability
to capture and represent uncertainty in the elicitation of
criteria weights and performance scores. However, the
applicability of these approaches are sometimes strictly
dependent on the specific form of MCDA used. Some
MCDA methods such as stochastic multi-criteria accept-
ability analysis are very closely tied to one specific
uncertainty approach (in this case, the probabilistic
approach). Some other MCDA methods allow the use of
multiple approaches for uncertainty while AHP and
PROMETHEE can be used with all approaches. It is yet
unclear whether other gaps in combinations are due to
fundamental methodological mismatches or if the combi-
nations are theoretically possible when there is more
familiarity with the MCDA methods and/or uncertainty
approaches.
With regard to time considerations, little time is required
for simple deterministic sensitivity analysis (assuming only
one or two parameters are changed simultaneously). The
process of assigning probability distributions in the prob-
abilistic approach can be time consuming for analysts
(when a large amount of data has to be modeled) and
decision makers (when distributions are elicited from
them). This duration can be reduced by assigning distri-
butions only to specific parameters. An example of when
this is relevant is when clinical data are available but
decision makers are unable or unwilling to provide criteria
weights [9, 27, 51, 66]. Time requirements in Bayesian
framework are more demanding because of the assignment
of not only probability distributions but also of dependence
relations in the form of conditional probabilities. Fuzzy set
theory requires the definition of fuzzy sets, which takes
time. Yet, when these are agreed upon they can be used
over multiple decisions. Grey theory is straightforward to
use in a group discussion setting [67]. If there is dis-
agreement about the value of model parameters in the
group, the lowest and highest of those can be used as
bounds for the gray number.
A final practical consideration is the knowledge required
to implement an uncertainty approach or to interpret its
results. Deterministic sensitivity analysis requires no
additional knowledge apart from knowledge about the
MCDA method that is used. Grey theory requires decision
makers to be able to give, define, and interpret ranges of
values. Probabilistic sensitivity analysis requires that
decision makers are familiar with probability distributions.
This is also the case with Bayesian frameworks, which in
addition require knowledge about Bayesian statistics.
Analysts applying the Bayesian framework need knowl-
edge about Bayesian programming languages such as
WINBUGS. Decision makers should be familiar with set
theory to be able to understand and apply fuzzy set theory.
When there is a disparity between the decision maker’s
current knowledge and the knowledge required from the
approach, there is a knowledge gap. This gap may lead to a
lack of confidence in the results of an (uncertainty) analysis
[68, 69], and bridging the gap can be time consuming.
Apart from the required knowledge, visual representations
of uncertainty are important factors for ease of interpreta-
tion. Decision makers applying deterministic sensitivity
analysis can obtain a tornado diagram, which ranks model
parameters on their ability to change the overall scores of
alternatives. For probabilistic and Bayesian approaches,
scatter plots or density plots can be used and Bayesian
networks can also be shown. Fuzzy sets can be visualized
through membership function plots similar to probabilistic
density plots. Because the outcomes of Dempster–Shafer
theory and grey theory analysis are the lower and upper
bounds of overall scores of treatments, graphs may be less
useful.
4.3 Limitations
Although the present review identified many applications,
the list is unlikely to be exhaustive owing to the large
amount of work on MCDA in different fields. Furthermore,
studies that did not mention uncertainty in their title or
abstract may have been missed. Although these are
potential limitations, the sample of studies provides suffi-
cient information to stimulate a discussion about the use of
approaches for uncertainty assessment. Approaches that
our review did not classify as such but that were mentioned
in the earlier reviews are risk-based approaches [17] and
possibility theory [18]. In risk-based approaches, an alter-
native’s performance score on a criterion will become
lower when that performance is uncertain (‘more risky’).
Possibility theory combines fuzzy set theory and evidential
reasoning [70]. Although these approaches were classified
as distinct approaches in the earlier reviews, there is con-
siderable overlap with our classification.
The aspects on which we compared the uncertainty
approaches are based on earlier literature, yet it is impor-
tant to acknowledge that for real-world decision making
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other aspects, depending on the specific decision and
decision maker(s), may be relevant. Further empirical
research with decision makers is needed to better assess the
usefulness and specific requirements of the approaches for
real-world decision making.
Following the classification of sources of uncertainty, all
approaches that were identified can be used to assess
uncertainty in the criteria weights and performance scores
as assigned by decision makers. However, no approaches
were identified to deal with structural uncertainty [2, 71–
73]. One explanation for this is that MCDA already facil-
itates an informed discussion and that this addresses
structural uncertainty. However, further work is recom-
mended to identify approaches to take into account struc-
tural uncertainty and ways to develop MCDA models to
incorporate these approaches [74, 75].
5 Conclusions and Recommendations
To our best knowledge, our review is the first to give an
overview of approaches to take into account uncertainty
in MCDA-supported decisions with a focus on the
approaches’ applicability to the context of healthcare
decision making. The review identified five approaches
to take into account uncertainty in MCDA-supported
decisions. In conclusion, the deterministic approach
seems most appropriate if the criteria weights or per-
formance scores are varied as a single value. The gray
approach seems most appropriate if only lower and upper
bounds are elicited. The other approaches can be used
flexibly across all three input modes. In a group decision
process where the opinions of several decision makers
are combined, the distribution input mode seems most
relevant, and this would argue for the probabilistic and
fuzzy set approaches that allow distributions [76]. From
the review it is concluded that deterministic sensitivity
analysis will likely be sufficient for most decisions
because it has the advantage of a straightforward
implementation. It also is an intuitive approach and
applicable for multiple MCDA approaches. Although
deterministic sensitivity analysis is useful in many
applications, the more complex approaches are especially
useful when uncertainty in multiple parameters has to be
taken into account simultaneously, when dependence
relations exist, or when there are no prohibitive time
constraints for uncertainty modeling.
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